Tetsuhiro Harakawa

416 total citations
14 papers, 336 citations indexed

About

Tetsuhiro Harakawa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Tetsuhiro Harakawa has authored 14 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Tetsuhiro Harakawa's work include Botulinum Toxin and Related Neurological Disorders (14 papers), Neurological disorders and treatments (13 papers) and Pain Mechanisms and Treatments (4 papers). Tetsuhiro Harakawa is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (14 papers), Neurological disorders and treatments (13 papers) and Pain Mechanisms and Treatments (4 papers). Tetsuhiro Harakawa collaborates with scholars based in Japan. Tetsuhiro Harakawa's co-authors include Akihiro Ginnaga, Yasushi Torii, Ryuji Kaji, Shunji Kozaki, Norio Akaike, Yoshitaka Goto, Masahito Wakita, Keiko Kato, Nakaba Sugimoto and Motohide Takahashi and has published in prestigious journals such as The Journal of Physiology, Toxicon and Frontiers in Neurology.

In The Last Decade

Tetsuhiro Harakawa

14 papers receiving 332 citations

Peers

Countries citing papers authored by Tetsuhiro Harakawa

Since Specialization

Citations

This map shows the geographic impact of Tetsuhiro Harakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhiro Harakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhiro Harakawa more than expected).

Fields of papers citing papers by Tetsuhiro Harakawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhiro Harakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhiro Harakawa. The network helps show where Tetsuhiro Harakawa may publish in the future.

Co-authorship network of co-authors of Tetsuhiro Harakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhiro Harakawa. A scholar is included among the top collaborators of Tetsuhiro Harakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhiro Harakawa. Tetsuhiro Harakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2 2014 ·Frontiers in Neurology ·Hidetaka Koizumi, Satoshi Goto, Shinya Okita, Ryoma Morigaki, Norio Akaike, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Ryuji Kaji	45
2	Botulinum neurotoxin A2 reduces incidence of seizures in mouse models of temporal lobe epilepsy 2013 ·Toxicon ·Keiko Kato, Norio Akaike, Tomoko Kohda, Yasushi Torii, Yoshitaka Goto, Tetsuhiro Harakawa, Akihiro Ginnaga, Ryuji Kaji, Shunji Kozaki	9
3	Transsynaptic inhibition of spinal transmission by A2 botulinum toxin 2012 ·The Journal of Physiology ·Norio Akaike, (unknown), Masahito Wakita, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Keiko Kato, Ryuji Kaji, Shunji Kozaki	50
4	Inhibition of Membrane Na+ Channels by A Type Botulinum Toxin at Femtomolar Concentrations in Central and Peripheral Neurons 2011 ·Journal of Pharmacological Sciences ·(unknown), Masahito Wakita, (unknown), (unknown), Satomi Iwata, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Shunji Kozaki, Norio Akaike	38
5	Effects of tetanus toxin on spontaneous and evoked transmitter release at inhibitory and excitatory synapses in the rat SDCN neurons 2011 ·Toxicon ·(unknown), (unknown), Masahito Wakita, (unknown), Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Yushi Ito, Norio Akaike	10
6	Type A1 but Not Type A2 Botulinum Toxin Decreases the Grip Strength of the Contralateral Foreleg Through Axonal Transport From the Toxin-Treated Foreleg of Rats 2011 ·Journal of Pharmacological Sciences ·Yasushi Torii, Norio Akaike, Tetsuhiro Harakawa, Keiko Kato, Nakaba Sugimoto, Yoshitaka Goto, (unknown), Tomoko Kohda, Shunji Kozaki, Ryuji Kaji, Akihiro Ginnaga	37
7	Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test 2010 ·Toxicon ·Yasushi Torii, (unknown), Nakaba Sugimoto, (unknown), Yoshitaka Goto, Tetsuhiro Harakawa, (unknown), Ryuji Kaji, Shunji Kozaki, Akihiro Ginnaga	51
8	Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses 2010 ·Toxicon ·Norio Akaike, Yushi Ito, (unknown), (unknown), Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Shunji Kozaki, Ryuji Kaji	27
9	Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins 2009 ·Toxicon ·Yasushi Torii, Yoshitaka Goto, Motohide Takahashi, (unknown), Tetsuhiro Harakawa, Takashi Sakamoto, Ryuji Kaji, Shunji Kozaki, Akihiro Ginnaga	36
10	Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats 2009 ·Toxicon ·Takashi Sakamoto, Yasushi Torii, Motohide Takahashi, (unknown), Yoshitaka Goto, (unknown), Tetsuhiro Harakawa, Akihiro Ginnaga, Shunji Kozaki, Ryuji Kaji	22
11	Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP) 2009 ·Toxicon ·Yasushi Torii, Motohide Takahashi, (unknown), Yoshitaka Goto, (unknown), Tetsuhiro Harakawa, Ryuji Kaji, Shunji Kozaki, Akihiro Ginnaga	4
12	Quantification of potency of neutralizing antibody to botulinum toxin by measuring the compound muscle action potential (CMAP) 2008 ·Toxicon ·Yasushi Torii, Yoshitaka Goto, (unknown), Takashi Sakamoto, Tetsuhiro Harakawa, Akihiro Ginnaga, Tomoko Kohda, Shunji Kozaki, Ryuji Kaji	4
13	The therapeutic window in rats of botulinum neurotoxin subtype A2 is wider than that of subtype A1, regardless of the presence of nontoxic proteins 2008 ·Toxicon ·Yoshitaka Goto, Yasushi Torii, (unknown), Tetsuhiro Harakawa, Akihiro Ginnaga, (unknown), Takashi Sakamoto, Shunji Kozaki, Ryuji Kaji	2
14	Comparison of immunogenicity between LL toxin from subtype A1 and NTX from subtype A2 2008 ·Toxicon ·(unknown), (unknown), (unknown), Yoshitaka Goto, Yasushi Torii, Shunji Kozaki, Tetsuhiro Harakawa, Akihiro Ginnaga	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact